Gallucci Giuseppina, Turazza Fabio Maria, Inno Alessandro, Canale Maria Laura, Silvestris Nicola, Farì Roberto, Navazio Alessandro, Pinto Carmine, Tarantini Luigi
Independent Researcher, 85025 Melfi, Italy.
Struttura Complessa di Cardiologia, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milano, Italy.
Int J Mol Sci. 2024 Apr 11;25(8):4232. doi: 10.3390/ijms25084232.
Atherosclerosis, a complex metabolic-immune disease characterized by chronic inflammation driven by the buildup of lipid-rich plaques within arterial walls, has emerged as a pivotal factor in the intricate interplay between cancer and cardiovascular disease. This bidirectional relationship, marked by shared risk factors and pathophysiological mechanisms, underscores the need for a comprehensive understanding of how these two formidable health challenges intersect and influence each other. Cancer and its treatments can contribute to the progression of atherosclerosis, while atherosclerosis, with its inflammatory microenvironment, can exert profound effects on cancer development and outcomes. Both cancer and cardiovascular disease involve intricate interactions between general and personal exposomes. In this review, we aim to summarize the state of the art of translational data and try to show how oncologic studies on cardiotoxicity can broaden our knowledge of crucial pathways in cardiovascular biology and exert a positive impact on precision cardiology and cardio-oncology.
动脉粥样硬化是一种复杂的代谢性免疫疾病,其特征是动脉壁内富含脂质的斑块积聚引发慢性炎症,已成为癌症与心血管疾病复杂相互作用中的一个关键因素。这种双向关系以共同的风险因素和病理生理机制为特征,凸显了全面了解这两大严峻健康挑战如何相互交叉和相互影响的必要性。癌症及其治疗可促使动脉粥样硬化进展,而动脉粥样硬化及其炎症微环境可对癌症发展和预后产生深远影响。癌症和心血管疾病均涉及一般暴露组和个人暴露组之间的复杂相互作用。在本综述中,我们旨在总结转化数据的现状,并试图展示关于心脏毒性的肿瘤学研究如何拓宽我们对心血管生物学关键途径的认识,并对精准心脏病学和心脏肿瘤学产生积极影响。